Literature DB >> 9703166

Interictal regional slow activity in temporal lobe epilepsy correlates with lateral temporal hypometabolism as imaged with 18FDG PET: neurophysiological and metabolic implications.

M Koutroumanidis1, C D Binnie, R D Elwes, C E Polkey, P Seed, G Alarcon, T Cox, S Barrington, P Marsden, M N Maisey, C P Panayiotopoulos.   

Abstract

OBJECTIVES: The phenomenon of interictal regional slow activity (IRSA) in temporal lobe epilepsy and its relation with cerebral glucose metabolism, clinical data, MRI, and histopathological findings was studied.
METHODS: Interictal 18F-fluorodeoxyglucose positron emission tomography (FDG PET) was performed under continuous scalp EEG monitoring in 28 patients with temporal lobe epilepsy not associated with intracranial foreign tissue lesions, all of whom subsequently underwent resective surgery. Regions of interest (ROIs) were drawn according to a standard template. IRSA was considered lateralised when showing a 4:1 or greater ratio of predominance on one side.
RESULTS: Sixteen patients (57%) had lateralised IRSA which was always ipsilateral to the resection and of maximal amplitude over the temporal areas. Its presence was significantly related to the presence of hypometabolism in the lateral temporal neocortex (p=0.0009). Logistic regression of the asymmetry indices for all measured cerebral regions confirmed a strong association between IRSA and decreased metabolism of the posterior lateral temporal neocortex only (p=0.009). No significant relation could be shown between slow activity and age at onset, duration of the epilepsy, seizure frequency, and MRI evidence for hippocampal atrophy. Furthermore, IRSA was not specifically related to mesial temporal sclerosis or any other pathology.
CONCLUSIONS: Interictal regional slowing in patients with temporal lobe epilepsy not associated with a mass lesion is topographically related to the epileptogenic area and therefore has a reliable lateralising, and possibly localising, value. Its presence is irrelevant to the severity or chronicity of the epilepsy as well as to lateral deactivation secondary to neuronal loss in the mesial temporal structures. Although slow EEG activity is generally considered as a non-specific sign of functional disturbance, interictal regional slowing in temporal lobe epilepsy should be conceptualised as a distinct electrographic phenomenon which is directly related to the epileptogenic abnormality. The strong correlation between interictal regional slowing and lateral temporal hypometabolism suggests in turn that the second may delineate a field of reduced neuronal inhibition which can receive interictal and ictal propagation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703166      PMCID: PMC2170184          DOI: 10.1136/jnnp.65.2.170

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Brain lesions that produce delta waves in the EEG.

Authors:  P Gloor; G Ball; N Schaul
Journal:  Neurology       Date:  1977-04       Impact factor: 9.910

2.  Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG.

Authors:  J Engel; T R Henry; M W Risinger; J C Mazziotta; W W Sutherling; M F Levesque; M E Phelps
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

Review 3.  The relative contributions of MRI, SPECT, and PET imaging in epilepsy.

Authors:  S S Spencer
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

4.  Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy.

Authors:  R A Radtke; M W Hanson; J M Hoffman; B J Crain; T S Walczak; D V Lewis; C Beam; R E Coleman; A H Friedman
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

5.  The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F 18.

Authors:  D B Leiderman; P Albert; M Balish; E Bromfield; W H Theodore
Journal:  Arch Neurol       Date:  1994-09

6.  Pathology of temporal lobe foci: correlation with CT, MRI, and PET.

Authors:  W H Theodore; D Katz; C Kufta; S Sato; N Patronas; P Smothers; E Bromfield
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

7.  In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy.

Authors:  T R Henry; K A Frey; J C Sackellares; S Gilman; R A Koeppe; J A Brunberg; D A Ross; S Berent; A B Young; D E Kuhl
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

8.  High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis.

Authors:  P E Valk; K D Laxer; N M Barbaro; S Knezevic; W P Dillon; T F Budinger
Journal:  Radiology       Date:  1993-01       Impact factor: 11.105

9.  Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography.

Authors:  M Hajek; A Antonini; K L Leenders; H G Wieser
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

10.  Interictal metabolic anatomy of mesial temporal lobe epilepsy.

Authors:  T R Henry; J C Mazziotta; J Engel
Journal:  Arch Neurol       Date:  1993-06
View more
  13 in total

1.  "Magnetic resonance imaging negative positron emission tomography positive" temporal lobe epilepsy: FDG-PET pattern differs from mesial temporal lobe epilepsy.

Authors:  R P Carne; M J Cook; L R MacGregor; C J Kilpatrick; R J Hicks; T J O'Brien
Journal:  Mol Imaging Biol       Date:  2007 Jan-Feb       Impact factor: 3.488

2.  The sensitivity and significance of lateralized interictal slow activity on magnetoencephalography in focal epilepsy.

Authors:  Dario J Englot; Srikantan S Nagarajan; Doris D Wang; John D Rolston; Danielle Mizuiri; Susanne M Honma; Mary Mantle; Phiroz E Tarapore; Robert C Knowlton; Edward F Chang; Heidi E Kirsch
Journal:  Epilepsy Res       Date:  2016-01-29       Impact factor: 3.045

3.  fMRI language dominance and FDG-PET hypometabolism.

Authors:  W D Gaillard; M M Berl; E S Duke; E Ritzl; S Miranda; C Liew; A Finegersh; A Martinez; I Dustin; S Sato; W H Theodore
Journal:  Neurology       Date:  2011-03-02       Impact factor: 9.910

4.  The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy.

Authors:  Beril Gok; George Jallo; Reza Hayeri; Richard Wahl; Nafi Aygun
Journal:  Neuroradiology       Date:  2012-12-08       Impact factor: 2.804

5.  Cortical glucose metabolism correlates negatively with delta-slowing and spike-frequency in epilepsy associated with tuberous sclerosis.

Authors:  Masaaki Nishida; Eishi Asano; Csaba Juhász; Otto Muzik; Sandeep Sood; Harry T Chugani
Journal:  Hum Brain Mapp       Date:  2008-11       Impact factor: 5.038

6.  Cortical glucose metabolism positively correlates with gamma-oscillations in nonlesional focal epilepsy.

Authors:  Masaaki Nishida; Csaba Juhász; Sandeep Sood; Harry T Chugani; Eishi Asano
Journal:  Neuroimage       Date:  2008-07-03       Impact factor: 6.556

7.  Quantitative analysis of simultaneous EEG features during PET studies for childhood partial epilepsy.

Authors:  Yun Jung Hur; Joon Soo Lee; Jong Doo Lee; Mi Jin Yun; Heung Dong Kim
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

8.  Surgical Outcomes and EEG Prognostic Factors After Stereotactic Laser Amygdalohippocampectomy for Mesial Temporal Lobe Epilepsy.

Authors:  Shasha Wu; Naoum P Issa; Maureen Lacy; David Satzer; Sandra L Rose; Carina W Yang; John M Collins; Xi Liu; Taixin Sun; Vernon L Towle; Douglas R Nordli; Peter C Warnke; James X Tao
Journal:  Front Neurol       Date:  2021-05-17       Impact factor: 4.003

9.  Neocortical temporal lobe epilepsy.

Authors:  Eduard Bercovici; Balagobal Santosh Kumar; Seyed M Mirsattari
Journal:  Epilepsy Res Treat       Date:  2012-07-16

10.  'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study.

Authors:  Ross P Carne; Terence J O'Brien; Christine J Kilpatrick; Lachlan R Macgregor; Lucas Litewka; Rodney J Hicks; Mark J Cook
Journal:  BMC Neurol       Date:  2007-06-24       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.